298 related articles for article (PubMed ID: 30355737)
41. Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination.
Rao CV; Tokumo K; Rigotty J; Zang E; Kelloff G; Reddy BS
Cancer Res; 1991 Sep; 51(17):4528-34. PubMed ID: 1831401
[TBL] [Abstract][Full Text] [Related]
42. Follow-up of tumor development in the colons of living rats and implications for chemoprevention trials: assessment of aspirin-difluoromethylornithine combination.
Raul F; Gosse F; Osswald AB; Bouhadjar M; Foltzer-Jourdainne C; Marescaux J; Soler L
Int J Oncol; 2007 Jul; 31(1):89-95. PubMed ID: 17549408
[TBL] [Abstract][Full Text] [Related]
43. Dietary polyamines promote the growth of azoxymethane-induced aberrant crypt foci in rat colon.
Paulsen JE; Reistad R; Eliassen KA; Sjaastad OV; Alexander J
Carcinogenesis; 1997 Oct; 18(10):1871-5. PubMed ID: 9363993
[TBL] [Abstract][Full Text] [Related]
44. Influence of cyclosporin A and alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on two rodent T-cell cancers in vivo.
Smart LM; MacLachlan G; Wallace HM; Thomson AW
Int J Cancer; 1989 Dec; 44(6):1069-73. PubMed ID: 2514149
[TBL] [Abstract][Full Text] [Related]
45. Chemoprevention of mouse colon tumors with difluoromethylornithine during and after carcinogen treatment.
Tempero MA; Nishioka K; Knott K; Zetterman RK
Cancer Res; 1989 Nov; 49(21):5793-7. PubMed ID: 2507137
[TBL] [Abstract][Full Text] [Related]
46. Polyamines and colon cancer.
Milovic V; Turchanowa L
Biochem Soc Trans; 2003 Apr; 31(2):381-3. PubMed ID: 12653643
[TBL] [Abstract][Full Text] [Related]
47. Expression of the transforming growth factor-beta gene during growth inhibition following polyamine depletion.
Patel AR; Li J; Bass BL; Wang JY
Am J Physiol; 1998 Aug; 275(2):C590-8. PubMed ID: 9688614
[TBL] [Abstract][Full Text] [Related]
48. Chemoprevention in prostate cancer: the role of difluoromethylornithine (DFMO).
Kadmon D
J Cell Biochem Suppl; 1992; 16H():122-7. PubMed ID: 1289667
[TBL] [Abstract][Full Text] [Related]
49. Polyamines and cancer: old molecules, new understanding.
Gerner EW; Meyskens FL
Nat Rev Cancer; 2004 Oct; 4(10):781-92. PubMed ID: 15510159
[TBL] [Abstract][Full Text] [Related]
50. Polyamines as biomarkers of cervical intraepithelial neoplasia.
Nishioka K; Melgarejo AB; Lyon RR; Mitchell MF
J Cell Biochem Suppl; 1995; 23():87-95. PubMed ID: 8747382
[TBL] [Abstract][Full Text] [Related]
51. Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: therapeutic implications.
Thomas T; Thomas TJ
Breast Cancer Res Treat; 1994 Feb; 29(2):189-201. PubMed ID: 8012036
[TBL] [Abstract][Full Text] [Related]
52. Polyamines reverse non-steroidal anti-inflammatory drug-induced toxicity in human colorectal cancer cells.
Hughes A; Smith NI; Wallace HM
Biochem J; 2003 Sep; 374(Pt 2):481-8. PubMed ID: 12793857
[TBL] [Abstract][Full Text] [Related]
53. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.
Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA
Cancer Res; 2000 Apr; 60(7):1864-70. PubMed ID: 10766173
[TBL] [Abstract][Full Text] [Related]
54. Effects of polyamine synthesis inhibitors on primary tumor features and metastatic capacity of human breast cancer cells.
Manni A; Washington S; Hu X; Griffith JW; Bruggeman R; Demers LM; Mauger D; Verderame MF
Clin Exp Metastasis; 2005; 22(3):255-63. PubMed ID: 16158253
[TBL] [Abstract][Full Text] [Related]
55. Differences in transglutaminase mRNA after polyamine depletion in two cell lines.
Wang JY; Viar MJ; Li J; Shi HJ; Patel AR; Johnson LR
Am J Physiol; 1998 Feb; 274(2):C522-30. PubMed ID: 9486143
[TBL] [Abstract][Full Text] [Related]
56. Effects of cyclosporin A and alpha-difluoromethylornithine on the growth of hamster pancreatic cancer in vitro.
Saydjari R; Townsend CM; Barranco SC; James E; Thompson JC
J Natl Cancer Inst; 1986 Nov; 77(5):1087-92. PubMed ID: 3022056
[TBL] [Abstract][Full Text] [Related]
57. Metabolomics of adherent mammalian cells by capillary electrophoresis-mass spectrometry: HT-29 cells as case study.
Ibáñez C; Simó C; Valdés A; Campone L; Piccinelli AL; García-Cañas V; Cifuentes A
J Pharm Biomed Anal; 2015 Jun; 110():83-92. PubMed ID: 25818703
[TBL] [Abstract][Full Text] [Related]
58. Modulation of azoxymethane-induced mutational activation of ras protooncogenes by chemopreventive agents in colon carcinogenesis.
Singh J; Kulkarni N; Kelloff G; Reddy BS
Carcinogenesis; 1994 Jul; 15(7):1317-23. PubMed ID: 8033306
[TBL] [Abstract][Full Text] [Related]
59. Polyamines in normal and cancer cells.
Luk GD; Casero RA
Adv Enzyme Regul; 1987; 26():91-105. PubMed ID: 3118650
[TBL] [Abstract][Full Text] [Related]
60. Novel cell culture model for prevention of carcinogenic risk in familial adenomatous polyposis syndrome.
Telang N; Katdare M
Oncol Rep; 2009 Apr; 21(4):1017-21. PubMed ID: 19288003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
